All month, we're celebrating our commitment to research and innovation. This week, we talk about the Maine Cancer Genomics Initiative, and how NECS is working with The Jackson Laboratory to help advance knowledge about cancer treatment.
Read more about this initiative here
This month, we're celebrating our commitment to innovation and clinical trials. For decades, our physicians and research team have been dedicated to increasing access to the latest therapies and trials for patients right here in Maine. Join us as we look back at our beginnings, and to the future of cancer treatment.
New England Cancer Specialists is thrilled to welcome Brian Haney, DO, to our Brunswick office. Dr. Haney joins our other two Brunswick physicians, Dr. David Benton and Dr. Eleni Nackos.
Read more about Dr. Haney's background and training here
New England Cancer Specialists was host to a special Hospice of Southern Maine breakfast on May 11th, featuring Joan Lunden. Lunden, who is working to further understanding and advance planning in the elder care space, addressed the group before her talk at the Thresholds Conference. Thresholds is an annual event of Hospice of Southern Maine. Dr. Tracey F. Weisberg, president of NECS and a specialist in breast cancer, introduced Lunden. The two became acquainted during Lunden's treatment for...
Our CEO, Steven D'Amato, spoke on a panel last week in Maryland about the role of pharmacy benefit managers (PBMs) in escalating drug prices, and the associated impact on patients and community oncology practices.
The Community Oncology Alliance has issued a white paper on this topic, and how PBMs increase the cost of care for many people across the country.
You can read a synopsis of the panel discussion here.
Our CEO, Steven D'Amato, and president, Dr. Tracey Weisberg, testified before the Health and Human Services Committee of the Maine Legislature yesterday. They were advocating for two bills that will ensure appropriate access for cancer patients to receive effective pain management.
Read Dr. Weisberg's testimony here
Read Steven D'Amato's testimony here
Read the policy position of the American Society of Clinical Oncology here